Biotherapeutics Cell Line Development Market to Reach a Worth US$99.8 Mn by 2022
The global Biotherapeutics Cell Line Development Market is characterized by a largely consolidated landscape, as the top two players held a sizeable share of 85% of the global market in 2015, finds Transparency Market Research (TMR). These companies are Beckman Coulter and Becton Dickinson and Company. The combined massive share held by these players is increasingly inhibiting the entry of new players, for whom the merger may be a potential option for getting a foothold in the market. The significant...
View full press release